Clobetasol Propionate Ophthalmic Suspension (BYQLOVI®) to Treat Ocular Inflammation and Pain after Uncomplicated Cataract Surgery

Journal:

Ophthalmology

Published:

2026-05-05

DOI:

10.1016/j.ophtha.2026.04.032

Affiliations:

5

Authors:

6

Go to article

Institutions	Authors	Share
AimMax Therapeutics, United States of America (USA)	2.000000	0.33
Comprehensive Eye Care, United States of America (USA)	1.000000	0.17
Levenson Eye Associates, United States of America (USA)	1.000000	0.17
Visionary Eye Institute, United States of America (USA)	1.000000	0.17
Center for Sight, Las Vegas, United States of America (USA)	1.000000	0.17

Interested in Ophthalmology and Optometry?